SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-059433
Filing Date
2013-11-07
Accepted
2013-11-07 09:00:54
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v358157_10q.htm 10-Q 1200112
2 CERTIFICATION v358157_ex31-1.htm EX-31.1 23409
3 CERTIFICATION v358157_ex32-1.htm EX-32.1 7857
  Complete submission text file 0001144204-13-059433.txt   7017086

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT lixt-20130930.xml EX-101.INS 1004996
5 XBRL TAXONOMY EXTENSION SCHEMA lixt-20130930.xsd EX-101.SCH 70850
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lixt-20130930_cal.xml EX-101.CAL 26159
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lixt-20130930_def.xml EX-101.DEF 227863
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lixt-20130930_lab.xml EX-101.LAB 373730
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lixt-20130930_pre.xml EX-101.PRE 273214
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 131198647
SIC: 2834 Pharmaceutical Preparations